Pr MD - Genelux Common Chief Officer
| GNLX Stock | 3.65 0.05 1.39% |
Executive
Pr MD is Chief Officer of Genelux Common
| Age | 78 |
| Address | 2625 Townsgate Road, Westlake Village, CA, United States, 91361 |
| Phone | 805 267 9889 |
| Web | https://www.genelux.com |
Genelux Common Management Efficiency
The company has return on total asset (ROA) of (0.8214) % which means that it has lost $0.8214 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.901) %, meaning that it created substantial loss on money invested by shareholders. Genelux Common's management efficiency ratios could be used to measure how well Genelux Common manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.07 in 2024. Return On Capital Employed is likely to rise to -1.08 in 2024. At this time, Genelux Common's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 25.4 M in 2024, whereas Net Tangible Assets are likely to drop (31.3 M) in 2024.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Joerg Koglin | Merck Company | N/A | |
| Gideon Blumenthal | Merck Company | N/A | |
| Peter Dannenbaum | Merck Company | N/A | |
| William White | Walmart | N/A | |
| Dalton III | Merck Company | 57 | |
| Stephanie Wissink | Walmart | N/A | |
| Yonglin Xie | Ping An Insurance | 55 | |
| Allyson Park | Walmart | N/A | |
| Matthew Miner | Walmart | N/A | |
| Michael Guptan | Walmart | N/A | |
| Itzchak Angel | MIRA Pharmaceuticals Common | N/A | |
| Chirfi Guindo | Merck Company | 58 | |
| Ruisheng Sheng | Ping An Insurance | 53 | |
Management Performance
| Return On Equity | -2.9 | ||||
| Return On Asset | -0.82 |
Genelux Common Leadership Team
Elected by the shareholders, the Genelux Common's board of directors comprises two types of representatives: Genelux Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genelux. The board's role is to monitor Genelux Common's management team and ensure that shareholders' interests are well served. Genelux Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genelux Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ralph BSc, Head Affairs | ||
| Sean JD, General Secretary | ||
| Lourie Zak, Chief Officer | ||
| Joseph Cappello, Chief Officer | ||
| Thomas JD, CEO Chairman | ||
| Caroline Jewett, VP Quality | ||
| Yong Yu, Senior Development | ||
| Pr MD, Chief Officer |
Genelux Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genelux Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.9 | ||||
| Return On Asset | -0.82 | ||||
| Current Valuation | 79.7 M | ||||
| Shares Outstanding | 27 M | ||||
| Shares Owned By Insiders | 21.98 % | ||||
| Shares Owned By Institutions | 22.51 % | ||||
| Number Of Shares Shorted | 2.32 M | ||||
| Price To Book | 5.68 X | ||||
| Price To Sales | 651.09 X | ||||
| Revenue | 170 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Genelux Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genelux Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genelux Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genelux Common Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genelux Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Genelux Stock analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Genelux Common's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genelux Common. If investors know Genelux will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genelux Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Quarterly Revenue Growth (0.95) | Return On Assets (0.82) | Return On Equity (2.90) |
The market value of Genelux Common is measured differently than its book value, which is the value of Genelux that is recorded on the company's balance sheet. Investors also form their own opinion of Genelux Common's value that differs from its market value or its book value, called intrinsic value, which is Genelux Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genelux Common's market value can be influenced by many factors that don't directly affect Genelux Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genelux Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genelux Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genelux Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.